The KD Pharma Group is a contract manufacturer that specializes in creating custom products that address the multi-faceted needs of the global pharmaceutical and nutrition marketplaces. It is also one of the largest Omega-3 fatty acid producers in the world with over 500 employees and a presence in the UK, Norway, Germany, Switzerland and the US. We employ a staff of industry leading scientists using superior technology, as well as cutting edge research and development to help accelerate your pharmaceutical and nutritional product development. This, combined with global support and unparalleled customer service, makes the KD Pharma Group, your Partner in Creating Health Solutions.
The KD Pharma Group technology portfolio is uniquely suited for developing, producing and marketing new molecules. Our capabilities include extraction, separation, chemical synthesis, encapsulation and packaging. The KD Pharma Group has successfully utilized these technologies to help bring Omega-3 API to market, develop a new molecular target for colon cancer, generate new ANDA approvals, and launch multiple new nutritional platforms for emerging conditions.
The KD Pharma Group has a historical emphasis on chromatographic separation in lipids and is the only company in the world capable of offering lipid and Omega-3 concentrates of either up to 99% in purity at a commercial scale. The KD Pharma Group can now offer EPA and DHA concentrates from algae at greater than 95% concentrations and next generation pre-resolving lipid mediators (PRMs) at the highest concentrations available.